In the last trading session, 7.33 million shares of the ENDRA Life Sciences Inc (NASDAQ:NDRA) were traded, and its beta was 0.87. Most recently the company’s share price was $0.40, and it changed around -$0.05 or -10.99% from the last close, which brings the market valuation of the company to $0.57M. NDRA currently trades at a discount to its 52-week high of $139.50, offering almost -34775.0% off that amount. We note from ENDRA Life Sciences Inc’s average daily trading volume that its 10-day average is 4.8 million shares, with the 3-month average coming to 1.09 million.
ENDRA Life Sciences Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended NDRA as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. ENDRA Life Sciences Inc is expected to report earnings per share of -2.0 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ENDRA Life Sciences Inc (NASDAQ:NDRA) trade information
Instantly NDRA has showed a red trend with a performance of -10.99% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 2.0500 on recent trading dayincreased the stock’s daily price by 80.49%. The company’s shares are currently down -99.63% year-to-date, but still down -80.34% over the last five days. On the other hand, ENDRA Life Sciences Inc (NASDAQ:NDRA) is -90.08% down in the 30-day period. We can see from the shorts that 4370.0 shares have been sold at a short interest cover period of 0.03 day(s).
ENDRA Life Sciences Inc (NDRA) estimates and forecasts
Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 90.00% in revenue this quarter, and will report an increase of 20.00% in the next quarter.
1 analysts expect ENDRA Life Sciences Inc to make 100k in revenue for the current ending quarter.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 48.47%.
NDRA Dividends
ENDRA Life Sciences Inc’s next quarterly earnings report is expected to be released in September.
ENDRA Life Sciences Inc (NASDAQ:NDRA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 3.79% of ENDRA Life Sciences Inc shares, and 1.10% of them are in the hands of institutional investors. The stock currently has a share float of 1.15%.
